4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

900.00p
   
  • Change Today:
    -60.00p
  • 52 Week High: 1,500.00p
  • 52 Week Low: 870.00p
  • Currency: UK Pounds
  • Shares Issued: 15.54m
  • Volume: 5,655
  • Market Cap: £139.85m
  • Beta: 0.03

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
87.36% above the market average87.36% above the market average87.36% above the market average87.36% above the market average87.36% above the market average
51.72% above the sector average51.72% above the sector average51.72% above the sector average51.72% above the sector average51.72% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
93.71% above the market average93.71% above the market average93.71% above the market average93.71% above the market average93.71% above the market average
82.61% above the sector average82.61% above the sector average82.61% above the sector average82.61% above the sector average82.61% above the sector average
Price Book Ratio
82.92% below the market average82.92% below the market average82.92% below the market average82.92% below the market average82.92% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
39.83% below the market average39.83% below the market average39.83% below the market average39.83% below the market average39.83% below the market average
6.67% below the sector average6.67% below the sector average6.67% below the sector average6.67% below the sector average6.67% below the sector average
Price Chg 3m
73.62% below the market average73.62% below the market average73.62% below the market average73.62% below the market average73.62% below the market average
60% below the sector average60% below the sector average60% below the sector average60% below the sector average60% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
22.6% below the market average22.6% below the market average22.6% below the market average22.6% below the market average22.6% below the market average
9.52% below the sector average9.52% below the sector average9.52% below the sector average9.52% below the sector average9.52% below the sector average
Momentum 20
87.89% below the market average87.89% below the market average87.89% below the market average87.89% below the market average87.89% below the market average
90.48% below the sector average90.48% below the sector average90.48% below the sector average90.48% below the sector average90.48% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
94.37% below the market average94.37% below the market average94.37% below the market average94.37% below the market average94.37% below the market average
72.41% below the sector average72.41% below the sector average72.41% below the sector average72.41% below the sector average72.41% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
54.42% below the market average54.42% below the market average54.42% below the market average54.42% below the market average54.42% below the market average
16.28% below the sector average16.28% below the sector average16.28% below the sector average16.28% below the sector average16.28% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
81.8% below the market average81.8% below the market average81.8% below the market average81.8% below the market average81.8% below the market average
44.83% below the sector average44.83% below the sector average44.83% below the sector average44.83% below the sector average44.83% below the sector average
Operating Profit Loss
85.09% below the market average85.09% below the market average85.09% below the market average85.09% below the market average85.09% below the market average
58.14% below the sector average58.14% below the sector average58.14% below the sector average58.14% below the sector average58.14% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
9.12% above the market average9.12% above the market average9.12% above the market average9.12% above the market average9.12% above the market average
40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average
Cash
46.29% above the market average46.29% above the market average46.29% above the market average46.29% above the market average46.29% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
18.50% above the market average18.50% above the market average18.50% above the market average18.50% above the market average18.50% above the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average
Buys 1y
70.54% above the market average70.54% above the market average70.54% above the market average70.54% above the market average70.54% above the market average
48.39% above the sector average48.39% above the sector average48.39% above the sector average48.39% above the sector average48.39% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4basebio Market Data

Currency UK Pounds
Share Price 900.00p
Change Today -60.00p
% Change -6.25 %
52 Week High 1,500.00p
52 Week Low 870.00p
Volume 5,655
Shares Issued 15.54m
Market Cap £139.85m
Beta 0.03

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
66.14% below the market average66.14% below the market average66.14% below the market average66.14% below the market average66.14% below the market average
2.33% above the sector average2.33% above the sector average2.33% above the sector average2.33% above the sector average2.33% above the sector average
Price Trend
25.7% below the market average25.7% below the market average25.7% below the market average25.7% below the market average25.7% below the market average
11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average
Income Not Available
Growth
59.34% above the market average59.34% above the market average59.34% above the market average59.34% above the market average59.34% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average

4basebio Dividends

No dividends found

Trades for 12-Aug-2025

Time Volume / Share Price
16:20 1,700 @ 870.00p
15:12 1,457 @ 900.00p
15:46 1,300 @ 900.00p
16:28 378 @ 879.00p
15:14 150 @ 920.00p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page